{"id":"W4305082751","doi":"10.1016/j.cytogfr.2022.10.003","title":"Pharmacological therapies and drug development targeting SARS-CoV-2 infection","year":2022,"lang":"en","type":"review","venue":"Cytokine & Growth Factor Reviews","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Drug development; Clinical trial; Drug; Tocilizumab; Coronavirus disease 2019 (COVID-19); Virus; Immunology; Monoclonal antibody; Antiviral drug; Disease; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Pharmacology; Antibody; Infectious disease (medical specialty); Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001736043,0.001017667,0.003899214,0.0005153043,0.0003967398,0.0001080494,0.0003969235,0.0003027808,0.0003301754],"category_scores_gemma":[0.0007764169,0.0006829101,0.0009039852,0.0009607854,0.0001500931,0.0001597518,0.000544915,0.001785568,0.0003164943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007593978,"about_ca_system_score_gemma":0.0007032603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006078599,"about_ca_topic_score_gemma":0.000008223272,"domain_scores_codex":[0.9945767,0.001072529,0.001714142,0.001119294,0.0007462265,0.0007711338],"domain_scores_gemma":[0.9981923,0.0004481728,0.0007079366,0.0004356625,0.0001154345,0.0001005401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003345966,0.0002051478,0.0008856426,0.02915446,0.0004003222,0.00009591861,0.0002877159,7.959761e-10,0.001259516,0.00001502719,0.00531223,0.9623505],"study_design_scores_gemma":[0.0006914763,0.0001502419,0.00007011648,0.004023098,0.0007737804,0.0001355393,0.000008473281,7.972861e-7,0.002147321,0.000008289097,0.9913446,0.0006462102],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004347002,0.9900464,0.00002556083,0.00005967006,0.0004377278,0.00411297,0.0000285711,0.0001935198,0.0007485923],"genre_scores_gemma":[0.00007329226,0.9896098,0.0002982008,0.007424517,0.0005577918,0.001732258,0.0001198029,0.0001335149,0.00005085351],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9860324,"threshold_uncertainty_score":0.9995622,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1660368980405735,"score_gpt":0.4223955339989406,"score_spread":0.2563586359583671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}